344 related articles for article (PubMed ID: 26914914)
1. Ion Channels in Neurological Disorders.
Kumar P; Kumar D; Jha SK; Jha NK; Ambasta RK
Adv Protein Chem Struct Biol; 2016; 103():97-136. PubMed ID: 26920688
[TBL] [Abstract][Full Text] [Related]
2. Relationship between symptom change, relapse activity and disability progression in multiple sclerosis.
Liu Y; Morgan C; Hornung L; Tyry T; Salter AR; Agashivala N; Belletti DA; Kim E; Fox RJ; Cofield SS; Cutter GR
J Neurol Sci; 2016 Mar; 362():121-6. PubMed ID: 26944131
[TBL] [Abstract][Full Text] [Related]
3. Fingolimod for multiple sclerosis and emerging indications: appropriate patient selection, safety precautions, and special considerations.
Ayzenberg I; Hoepner R; Kleiter I
Ther Clin Risk Manag; 2016; 12():261-72. PubMed ID: 26929636
[TBL] [Abstract][Full Text] [Related]
4. Epigenetics in Multiple Sclerosis: Molecular Mechanisms and Dietary Intervention.
Rito Y; Torre-Villalvazo I; Flores J; Rivas V; Corona T
Cent Nerv Syst Agents Med Chem; 2018 Jan; 18(1):8-15. PubMed ID: 26915659
[TBL] [Abstract][Full Text] [Related]
5. The Use of Oral Disease-Modifying Therapies in Multiple Sclerosis.
Kretzschmar B; Pellkofer H; Weber MS
Curr Neurol Neurosci Rep; 2016 Apr; 16(4):38. PubMed ID: 26944956
[TBL] [Abstract][Full Text] [Related]
6. Restless legs syndrome associated with major diseases: A systematic review and new concept.
Trenkwalder C; Allen R; Högl B; Paulus W; Winkelmann J
Neurology; 2016 Apr; 86(14):1336-1343. PubMed ID: 26944272
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulation by vitamin D in multiple sclerosis: More than IL-17.
Smolders J; Muris AH; Damoiseaux J
J Neuroimmunol; 2016 Mar; 292():79-80. PubMed ID: 26943962
[No Abstract] [Full Text] [Related]
8. QualiCOP: real-world effectiveness, tolerability, and quality of life in patients with relapsing-remitting multiple sclerosis treated with glatiramer acetate, treatment-naïve patients, and previously treated patients.
Ziemssen T; Calabrese P; Penner IK; Apfel R
J Neurol; 2016 Apr; 263(4):784-91. PubMed ID: 26914926
[TBL] [Abstract][Full Text] [Related]
9. Drug-Induced Reaction With Eosinophilia and Systemic Symptoms: A Review.
Alotaibi M
Cureus; 2023 Mar; 15(3):e35701. PubMed ID: 37012934
[TBL] [Abstract][Full Text] [Related]
10. Neurotransmitters Regulation and Food Intake: The Role of Dietary Sources in Neurotransmission.
Gasmi A; Nasreen A; Menzel A; Gasmi Benahmed A; Pivina L; Noor S; Peana M; Chirumbolo S; Bjørklund G
Molecules; 2022 Dec; 28(1):. PubMed ID: 36615404
[TBL] [Abstract][Full Text] [Related]
11. An inventory of medicinal products causing skin rash: Clinical and regulatory lessons.
Ancuceanu R; Dinu M; Furtunescu F; Boda D
Exp Ther Med; 2019 Dec; 18(6):5061-5071. PubMed ID: 31798726
[TBL] [Abstract][Full Text] [Related]
12. Dermatologic side effects of psychotropic medications.
Mitkov MV; Trowbridge RM; Lockshin BN; Caplan JP
Psychosomatics; 2014; 55(1):1-20. PubMed ID: 24099686
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous Adverse Events in Newly Approved FDA Non-cancer Drugs: A Systematic Review.
Macklis PC; Dulmage B; Evans B; Rosenbach M; Gudjonsson JE; Kaffenberger BH
Drugs R D; 2020 Sep; 20(3):171-187. PubMed ID: 32557274
[TBL] [Abstract][Full Text] [Related]
14. Adverse cutaneous reactions to medications.
Kroshinsky D
Clin Dermatol; 2020; 38(6):605-606. PubMed ID: 33341194
[No Abstract] [Full Text] [Related]
15. Cutaneous reactions to neurologic drugs.
Ahrens EM
Neurol Clin; 1987 Aug; 5(3):499-514. PubMed ID: 2957583
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous Adverse Effects of Neurologic Medications.
Bahrani E; Nunneley CE; Hsu S; Kass JS
CNS Drugs; 2016 Mar; 30(3):245-67. PubMed ID: 26914914
[TBL] [Abstract][Full Text] [Related]
17. Neurological and Neuropsychiatric Adverse Effects of Dermatologic Medications.
Liu M; Huang YY; Hsu S; Kass JS
CNS Drugs; 2016 Dec; 30(12):1149-1168. PubMed ID: 27832476
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
